Core Scientific, Inc. (CORZ)
NASDAQInformation TechnologySoftware - InfrastructureSnapshot 2026-09-04
$17.89-0.06%
Close 2026-09-04 · 1-day change
NASDAQInformation TechnologySoftware - InfrastructureSnapshot 2026-09-04
Research Workspace
Put CORZ beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Systems Software is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar broken — EPS improves from -$1.04 in 2026 to positive $0.30 in 2027: FY27 EPS $0.14 vs $0.30 target.
View ThesisRevenue growth is accelerating — up about 26% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 34%, softest on returns on capital.
View QualityManagement screens weak on earnings delivery, margins.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 3% on a typical day and fell roughly 45% in its worst 12-month stretch.
View RiskCORZ must improve its earnings to justify its current price. The company aims for growth through a strategic acquisition to expand its power portfolio. Revenue grew 108% year over year, but the last quarter missed expectations. CORZ trades at 13× price-to-sales, above the peer median of 5×. This suggests the price reflects less growth than expected. The primary risk is a 54% chance of missing next quarter's earnings. Peer multiples imply a price about 36% above where it trades. This read is provisional.
Trailing returns as of 2026-09-04. CORZ is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 17 analysts currently covering CORZ (as of Sep 2026).
Based on 9 Wall Street analysts offering 12-month price targets for CORZ in the last 4 months.
Continue this research
Compare CORZ with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| CORZ Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 3 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Systems Software — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put CORZ next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Strategic acquisition to expand power portfolio
Acquisition enhances power portfolio, aligning with growth objectives.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $17.89
The last 12 months of price, then the range of analyst 12-month targets from today’s $17.89.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
New board member enhances leadership and strategic direction.
Positioning in AI tech aligns with growth strategy.
Utilizing talent for AI strategy supports growth objectives.
Rising build costs may strain capital allocation efforts.
Proven AI beneficiary status supports growth narrative.